1. HBW Insight
  2. >>Health
  3. >>Business
  4. >>Marketing & Advertising

Crown Grows With Keri From GSK, Which Says Little On Consumer Pending JV Launch With Pfizer

 
• By Malcolm Spicer

Sales to Crown Labs didn't breach GSK's attention when it reported its Q1 results, with its consumer health discussion limited to general figures on regions and product categories. Pfizer offered even less about its consumer health operations and plans with its Q1 report.For Crown Labs, landing North American rights to Keri brand marks another step toward offering comprehensive skin care selection.

Crown Laboratories, Inc offices
Crown Labs lands North American rights to the Keri brand, its second deal with GSK in five months.

GlaxoSmithKline PLC and Pfizer Inc.'s planned consumer health joint venture will have one less product to manage as GSK continues offloading non-core brands with the sale of the Keri line to skin care product marketer Crown Laboratories Inc.

The April 30 deal didn't make GSK's presentation for its 2019 first-quarter results a day later. The UK big pharma's...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Marketing & Advertising

EU Green Claims Directive: Commission Says It ‘Has Not Withdrawn’ From Negotiations

 
• By David Ridley

What's going on with the EU Green Claims Directive? HBW Insight speaks to the European Commission, Parliament and Council to find out why trilogue negotiations seem to have stalled.

Scope Launches Eyelid-Friendly Eye Cream In The UK

 
• By David Ridley

Eyelids have the "thinnest, most sensitive skin on the body" and are "highly prone to dehydration," which is why Scope has launched new Optase Life Sensitive Eye Daily Renewal Cream.

P&G’s Crest Gum Detoxify Ad Claims Rinsed Clean In NAD Review On GuruNanda Challenge

 
• By Malcolm Spicer

P&G provided sufficient support for all challenged claims, including the “Gum Detoxify” brand used on the product label and in advertising on the website and in magazine detail pages.

German Associations Call For EU Green Claims Directive Trilogue Suspension

 
• By David Ridley

Pharma Deutschland is one of 21 German associations calling for trilogue negotiations in relation to the EU Green Claims Directive to be suspended while a “comprehensive and independent written impact assessment” is undertaken.

More from Business

PharmaSGP Increases Sales Forecast Ahead Of Delisting

 
• By Tom Gallen

German consumer health player expects 2025 sales to be €10m higher than previously forecast after a better than predicted showing in the year-to-date.

Change In P&G’s Helm Coming As Planning For Impact From Tariff Increases In Difficulty

 
• By Malcolm Spicer

Even as CEO Jon Moeller and lead board member Joe Jiminez as well as analysts state confidence the firm’s growth strategy will continue with the executive suite change, the impact of tariff policies could put a dent in its results.

Reckitt Leans On Europe As It Resets Mucinex In US

 
• By Tom Gallen

Decision to reformulate Mucinex sinus products without phenylephrine hits Reckitt's Q2 sales but the firm says it is preparing for upcoming cold & flu season with new marketing push.